Thomas Stankovich, Chief Financial Officer at ReShape Lifesciences Inc. (RSLS), bought 17,702 shares at $1.52 ($27K) on 2023-06-30, disclosed to the SEC on 2023-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| Filing → |
| RSLS | SELL | 2023-07-19 | $156 | — | Filing → |
| RSLS | SELL | 2023-03-07 | $4K | — | Filing → |
| RSLS | SELL | 2022-12-20 | $125K | — | Filing → |